← All Sponsors
SPONSOR

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Total Trials
12
Recruiting
12
Phases
Phase 1, EARLY_Phase 1, Phase 2

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology is a clinical research sponsor with 12 registered studies on ClinicalTrials.gov, of which 12 are actively recruiting participants. Research covers conditions including Gastric Cancer, Sarcopenia, Mechanism, Cirrhosis.

The trial portfolio spans Phase 1, EARLY_Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

How many clinical trials has Union Hospital, Tongji Medical College, Huazhong University of Science and Technology sponsored?
ClinicalMetric currently tracks 12 clinical trials sponsored by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, of which 12 are actively recruiting participants. These trials cover conditions including Gastric Cancer, Sarcopenia, Mechanism. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Union Hospital, Tongji Medical College, Huazhong University of Science and Technology research focus on?
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology clinical trials span Gastric Cancer, Sarcopenia, Mechanism, Cirrhosis, Relapsed/Refractory B-cell Malignancies, and additional conditions. The research pipeline includes Phase 1, EARLY_Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Union Hospital, Tongji Medical College, Huazhong University of Science and Technology clinical trial?
To participate in a Union Hospital, Tongji Medical College, Huazhong University of Science and Technology trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Union Hospital, Tongji Medical College, Huazhong University of Science and Technology trials with current recruitment status updated daily.

Clinical Trials by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

NCT07776067
Recruiting

CT Imaging and Clinical Features to Predict Outcomes in Patients With Gastric Cancer

Gastric Cancer
NCT06794853
Recruiting

Mechanism of TIPS to Improve Sarcopenia

Sarcopenia
NCT07309900 Phase 1
Recruiting

IASO208 Injection in the Treatment of Relapsed/Refractory B-cell Malignancies

Relapsed/Refractory B-cell Malignancies
NCT05445011 Phase 1
Recruiting

Anti-FLT3 CAR-T Cell (TAA05 Cell Injection) in the Treatment of Relapsed / Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia
NCT06346938
Recruiting

The Clinical Significance of CT-based Biomarkers in the Classification and Prognosis of Bronchiectasis

Bronchiectasis
NCT07474103
Recruiting

SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC

Rectal Cancer, Adenocarcinoma
NCT07347860 EARLY_Phase 1
Recruiting

Clinical Study of (A-319) in the Treatment of Active Rheumatoid Arthritis

Rheumatoid Arthritis (RA)
NCT06245746 Phase 1
Recruiting

UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia

Acute Myeloid Leukemia
NCT07339332 EARLY_Phase 1
Recruiting

A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Dynamics of Universal CD19 / 20 Car-t Cell Injection in Moderate to Severe Refractory Systemic Lupus Erythematosus

Systemic Lupus Erythematosus (SLE)
NCT07424664 Phase 2
Recruiting

A Single-arm, Multicenter Clinical Study of Becotatug Vedotin Combined With Zimberelimab in the Treatment of Recurrent and Metastatic Cervical Cancer, Vulvar Cancer and Vaginal Cancer

Uterine Cervical Neoplasms, Recurrent; Uterine Cervical Neoplasms, Metastatic; Vulvar Neoplasms; Vaginal Neoplasms
NCT06491472 Phase 2
Recruiting

Ivonescimab(AK112/SMT112) in Combination With Stereotactic Body Radiation Therapy and Chemotherapy in Patients With Pancreatic Cancer

Pancreatic Cancer
NCT07552467
Recruiting

Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors

Pancreatic Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology